COVERAGE HUB
$PGEN
2 articles in last 30 days
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
BULLISH
TOTAL VIEWS
0
2-DAY GRADE TIMELINE
2026-06-12
TODAY
RECENT COVERAGE · 2 ARTICLES
Precigen Gains Advantage As PAPZIMEOS Granted Orphan Drug Exclusivity By FDA; Long-Term Data From Clinica
Precigen (PGEN) has secured orphan drug exclusivity designation from the FDA for PAPZIMEOS, a narrowly-focused therapeutic addressing...
Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...
ADIL announced the acquisition of Azora Therapeutics, a strategic move designed to expand its clinical pipeline and enhance its...
RELATED TICKERS